Serum antinuclear antibodies associate with worse prognosis in AQP4-positive neuromyelitis optica spectrum disorder.
Rong FanYuefeng ZhangYunqi XuJiayi TongZhigang ChenMeifeng GuWenkui FanYong ChenFuhua PengYing JiangPublished in: Brain and behavior (2020)
Antinuclear antibodies seem to be associated with more severe disease activity in NMOSD patients.